Antiretroviral pre-exposure prophylaxis: A new opportunity to slow HIV spread in India.
作者信息
Mayer Kenneth H, Chandhiok Nomita, Thomas Beena
机构信息
Fenway Health (Medical Research Director), Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA 02215, USA.
出版信息
Indian J Med Res. 2016 Feb;143(2):125-8. doi: 10.4103/0971-5916.180194.
Abstract
摘要
相似文献
1
Antiretroviral pre-exposure prophylaxis: A new opportunity to slow HIV spread in India.
Indian J Med Res. 2016 Feb;143(2):125-8. doi: 10.4103/0971-5916.180194.
2
Post-exposure prophylaxis for HIV infection.
Expert Rev Anti Infect Ther. 2011 Apr;9(4):431-42. doi: 10.1586/eri.11.20.
3
Antiretroviral pre-exposure prophylaxis for HIV prevention is highly effective in community settings.
Evid Based Med. 2016 Jun;21(3):99. doi: 10.1136/ebmed-2016-110403. Epub 2016 Mar 30.
4
Antiretrovirals for HIV prevention: when should they be recommended?
Expert Rev Anti Infect Ther. 2014 Apr;12(4):431-45. doi: 10.1586/14787210.2014.896739.
5
The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India.
Clin Infect Dis. 2005 Nov 15;41(10):1525-8. doi: 10.1086/497267. Epub 2005 Oct 13.
6
COVID-19 and AIDS: Outcomes from the coexistence of two global pandemics and the importance of chronic antiretroviral therapy.
J Med Virol. 2021 Feb;93(2):641-643. doi: 10.1002/jmv.26416. Epub 2020 Aug 21.
7
Do resistance patterns vary between different FTC containing drug regimens?
J Infect. 2014 May;68(5):503-5. doi: 10.1016/j.jinf.2014.01.011. Epub 2014 Feb 8.
8
Advances in antiretroviral therapy.
Top HIV Med. 2003 May-Jun;11(3):97-127.
9
Drug-resistant HIV.
AIDS Read. 2001 Aug;11(8):384-5.
10
Antiretroviral update: recent advances expand options for patients with HIV.
Adv Nurse Pract. 2004 Nov;12(11):53-4, 56.
引用本文的文献
1
Stated preferences for new HIV prevention technologies among men who have sex with men in India: A discrete choice experiment.
PLoS One. 2024 Jul 24;19(7):e0289396. doi: 10.1371/journal.pone.0289396. eCollection 2024.
2
Demonstration project of oral TDF-containing PrEP, administered, once-daily orally to men having sex with men (MSM) and transgender women (TGW) in India: Study protocol.
PLoS One. 2023 Jun 23;18(6):e0287454. doi: 10.1371/journal.pone.0287454. eCollection 2023.
3
PrEP in India's HIV Prevention Policy in the Era of Social Media and Sex Positivity.
Cent Asian J Glob Health. 2020 Mar 31;9(1):e407. doi: 10.5195/cajgh.2020.407. eCollection 2020.
4
Factors Influencing Willingness to Use Human Immunodeficiency Virus Preexposure Prophylaxis Among Transgender Women in India.
Transgend Health. 2021 Apr 16;6(2):64-73. doi: 10.1089/trgh.2019.0076. eCollection 2021 Apr.
5
The Ashodaya PrEP project: Lessons and implications for scaling up PrEP from a community-led demonstration project among female sex workers in Mysore, India.
Glob Public Health. 2020 Jun;15(6):889-904. doi: 10.1080/17441692.2020.1724316. Epub 2020 Feb 18.
6
Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.
AIDS Patient Care STDS. 2020 Feb;34(2):92-98. doi: 10.1089/apc.2019.0237. Epub 2020 Jan 17.
7
Adverse drug reaction monitoring in patients on antiretroviral therapy in a tertiary care hospital in Eastern India.
Indian J Pharmacol. 2017 May-Jun;49(3):223-228. doi: 10.4103/ijp.IJP_304_16.
本文引用的文献
1
Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.
JAMA Intern Med. 2016 Jan;176(1):75-84. doi: 10.1001/jamainternmed.2015.4683.
2
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.
Lancet. 2016 Jan 2;387(10013):53-60. doi: 10.1016/S0140-6736(15)00056-2. Epub 2015 Sep 9.
3
Acceptability of HIV Pre-Exposure Prophylaxis (PrEP) and Implementation Challenges Among Men Who Have Sex with Men in India: A Qualitative Investigation.
AIDS Patient Care STDS. 2015 Oct;29(10):569-77. doi: 10.1089/apc.2015.0143. Epub 2015 Sep 8.
4
Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges.
Drugs. 2015 Feb;75(3):243-51. doi: 10.1007/s40265-015-0355-4.
5
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
N Engl J Med. 2015 Feb 5;372(6):509-18. doi: 10.1056/NEJMoa1402269.
6
Acceptability of oral and topical HIV chemoprophylaxis in India: implications for at-risk women and men who have sex with men.
Sex Health. 2014 Jul;11(2):171-9. doi: 10.1071/SH13067.
7
Acceptability of coitally-associated versus daily use of 1% tenofovir vaginal gel among women in Pune, India.
Int Health. 2012 Mar;4(1):63-9. doi: 10.1016/j.inhe.2011.11.003.
8
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet. 2013 Jun 15;381(9883):2083-90. doi: 10.1016/S0140-6736(13)61127-7. Epub 2013 Jun 13.
9
Violence and HIV risk among female sex workers in Southern India.
Sex Transm Dis. 2013 Feb;40(2):168-74. doi: 10.1097/olq.0b013e31827df174.
10
A systematic review of HIV/AIDS-related stigma and discrimination in India: current understanding and future needs.
SAHARA J. 2011;8(3):138-49. doi: 10.1080/17290376.2011.9724996.
Zotero 插件